Land: USA
Språk: engelsk
Kilde: NLM (National Library of Medicine)
Betamethasone Valerate (UNII: 9IFA5XM7R2) (Betamethasone - UNII:9842X06Q6M)
Rebel Distributors Corp.
Betamethasone Valerate
Betamethasone Valerate 1 mg in 1 g
TOPICAL
PRESCRIPTION DRUG
Betamethasone valerate cream is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Betamethasone valerate cream is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Betamethasone Valerate Cream USP, 0.1% is supplied in 15 gram (NDC 21695-583-15) and 45 gram (NDC 21695-584-45) tubes. Store at 20° - 25°C (68° - 77°F) [see USP Controlled Room Temperature]. Protect from freezing.
Abbreviated New Drug Application
BETAMETHASONE VALERATE- BETAMETHASONE VALERATE CREAM REBEL DISTRIBUTORS CORP. ---------- BETAMETHASONE VALERATE CREAM USP, 0.1% RX ONLY FOR EXTERNAL USE ONLY. NOT FOR OPHTHALMIC USE. DESCRIPTION Betamethasone Valerate Cream USP, 0.1% contains a topical corticosteroid, betamethasone valerate. The topical corticosteroids constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. Betamethasone valerate is chemically designated as Pregna-1, 4-diene-3, 20-dione, 9-fluoro-11, 21- dihydroxy-16-methyl-17 [(1-oxopentyl) oxy], (11β, 16β)-. MF: C H FO MW: 476.58 Each gram of Betamethasone Valerate Cream USP, 0.1% contains: 1.2 mg betamethasone valerate USP (equivalent to 1.0 mg betamethasone) with mineral oil, white petrolatum, ceteth-20, cetyl alcohol, stearyl alcohol, propylene glycol, phosphoric acid, sodium phosphate monobasic, sodium hydroxide, purified water and 4-chloro-m-cresol as a preservative. CLINICAL PHARMACOLOGY Betamethasone valerate cream as a topical corticosteroid has anti-inflammatory, antipruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man. PHARMACOKINETICS The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle, the integrity of the epidermal barrier, and the use of occlusive dressings. Betamethasone valerate cream can be absorbed from normal intact skin. Inflammation and/or other disease processes in the skin increase percutaneous absorption. Occlusive dressings substantially increase the percutaneous absorption of topical corticosteroids. Thus, occlusive dressings may be a valuable therapeutic adjunct for treatment of resistant de read_full_document